Cited by 319Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

Plastic Neuronal Remodeling Is Impaired in Patients with Alzheimer’s Disease Carrying Apolipoprotein ε4 Allele

Open access
Arendt, Thomas, Schindler, Cornelia, Brückner, Martina K., Eschrich, Klaus, Bigl, Volker, Zedlick, Dyrk, Marcova, Lena·1997·The Journal of Neuroscience

Abstract

A relationship between the apolipoprotein E (apoE) genotype and the risk to develop Alzheimer’s disease has been established recently. Apolipoprotein synthesis is implicated in developmental processes and in neuronal repair of the adult nervous system. In the present study, we investigated the influence of the apolipoprotein polymorphism on the severity of neuronal degeneration and the extent of plastic dendritic remodeling in Alzheimer’s disease. Changes in length and arborization of dendrites of Golgi-impregnated neurons in the basal nucleus of Meynert, locus coeruleus, raphe magnus nucleus, medial amygdaloid nucleus, pedunculopontine tegmental nucleus, and substantia nigra were analyzed after three-dimensional reconstruction. Patients with either one or two apoE ε4 alleles not only showed a more severe degeneration in all areas investigated than in patients lacking the apoE 4 allele but also revealed significantly less plastic dendritic changes. ApoE ε4 allele copy number, furthermore, had a significant effect on the pattern of dendritic arborization. Moreover, the relationship between the intensity of dendritic growth and both the extent of neuronal degeneration and the stage of the disease seen in patients lacking the apoE ε4 allele was very weak in the presence of one ε4 allele and completely lost in patients homozygous for the ε4 allele. The results provide direct evidence that neuronal reorganization is affected severely in patients with Alzheimer’s disease carrying the apoE ε4 allele. This impairment of neuronal repair might lead to a more rapid functional decompensation, thereby contributing to an earlier onset and more rapid progression of the disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.17-02-00516.1997

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Findings from human subjects are not conclusive in regard to the effects of apoE on neuronal processes.

    “In addition, findings from human subjects are not conclusive in regard to the effects of apoE on neuronal processes (Arendt et al., 1997; Schonheit et al., 2007).”

    From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Arendt et al., 1997

    The Discussion says the study cannot determine whether apoE affects neuronal number and branching in people without Alzheimer’s disease, because no controls carried the ε4 allele. But it also reports a relationship between apoE genotype and neuronal degeneration and dendritic changes in patients with Alzheimer’s disease. The citation therefore supports a specific limitation, not the broader claim that human findings are inconclusive. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 13

  1. Arendt T, Bru ¨ckner MK (1991) Preserved neuronal plasticity in the reticular core during aging and in Alzheimer's disease. In: Alzheimer's disease: advances in basic research and therapies (Wurtman RJ, Corkin SH, Growdon JH, eds), pp 250 -256. Cambridge, MA: Center for Brain Sciences and Metabolism Charitable Trust.
  2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
  3. Esiri MM, Pearson RCA, Steele JE, Bowen DM, Powell TPS (1990) A quantitative study of the neurofibrillary tangles and the choline acetyl- transferase activity in the cerebral cortex and the amygdala in Alzhei- mer's disease. J Neurol Neurosurg Psychiatry 53:161-165.
  4. Flood DG, Stechna SB, Hanks SD (1991) Stability of dendritic extent in neurons of the vertical limb of the diagonal band of Broca in Alzhei- mer's disease. In: Alzheimer's disease: basic mechanisms, diagnosis, and therapeutic strategies (Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM, eds), pp 137-143. New York: Wiley.
  5. Huang DY, Goedert M, Jakes R, Weisgraber KH, Garner CC, Saunders AM, Pericak-Vance MA, Schmechel DE, Roses AD, Strittmatter WJ (1994) Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease. Neurosci Lett 182:55-58.
  6. Huang DY, Weisgraber KH, Goedert M, Saunders AM, Roses AD, Strittmatter WJ (1995) ApoE3 binding to tau tandem repeat I is abol- ished by tau serine262 phosphorylation. Neurosci Lett 192:209 -212.
  7. Masliah E, Mallory M, Alford M, Ge N, Mucke L (1995a) Abnormal synaptic regeneration in happ(695), transgenic, and apoE knockout mice. In: Research advances in Alzheimer's disease and related disor- ders (Iqbal K, ed), pp 405-414. Chichester, UK: Wiley.
  8. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-Maclachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
  9. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) In- creased amyloid beta-peptide deposition in cerebral cortex as a conse- quence of apolipoprotein-E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90:9649 -9653.
  10. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993a) Apolipoprotein E: high-avidity binding to ␤-amyloid and increased frequency of type 4 allele in late- onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90:1977-1981.
  11. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993b) Binding of human apolipoprotein-E to synthetic amyloid beta-peptide isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90:8098 -8102.
  12. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericakvance M, Schmechel D, Roses AD (1994a) Isoform-specific interactions of apolipoprotein E with microtubule- associated protein tau: implications for Alzheimer's disease. Proc Natl Acad Sci USA 91:11138 -11186.
  13. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Han S-H, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD (1994b) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 125:163-171.

Cited by

Sorted by citations

Authors
Arendt, T., Schindler, C., Brückner, M. K., Eschrich, K., Bigl, V., Zedlick, D., & Marcova, L.
Affiliations
Leipzig University (DE)
Venue
The Journal of Neuroscience
Published
1997-01-15
Volume
17
Issue
2
Pages
516-529
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2143470402
Cited by
319
References
6
Citations by year
2026: 2 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 9 · 2020: 10 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 8 · 2014: 10 · 2013: 11 · 2012: 6
FWCI
13.93
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Bundesministerium für Bildung und Forschung (01KS9504/1)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Alzheimer's disease, apolipoprotein E, APOE ε4, neuroplasticity, dendritic remodeling, dendritic branching, neurodegeneration, basal ganglia, locus coeruleus, substantia nigra, medial amygdala, pedunculopontine nucleus, disease progression, genetic risk
MeSH terms
Aged, Aged, 80 and over, Alleles, Alzheimer Disease, Apolipoproteins E, Brain, Choline O-Acetyltransferase, Dendrites, Female, Genotype, Humans, Male, Nerve Degeneration, Nerve Tissue Proteins, Neuronal Plasticity, Neurons, Polymorphism, Genetic, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review